Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Lung Cancer

  Free Subscription


Articles published in Arch Pathol Lab Med

Retrieve available abstracts of 32 articles:
HTML format
Text format



Single Articles


    November 2017
  1. DRIVER BR, Miller RA, Miller T, Deavers M, et al
    Programmed Death Ligand-1 (PD-L1) Expression in Either Tumor Cells or Tumor-Infiltrating Immune Cells Correlates With Solid and High-Grade Lung Adenocarcinomas.
    Arch Pathol Lab Med. 2017;141:1529-1532.
    PubMed     Text format     Abstract available


    September 2017
  2. WOO JS, Reddy OL, Koo M, Xiong Y, et al
    Application of Immunohistochemistry in the Diagnosis of Pulmonary and Pleural Neoplasms.
    Arch Pathol Lab Med. 2017;141:1195-1213.
    PubMed     Text format     Abstract available


    August 2017
  3. PENG Y, Butt YM, Chen B, Zhang X, et al
    Update on Immunohistochemical Analysis in Breast Lesions.
    Arch Pathol Lab Med. 2017;141:1033-1051.
    PubMed     Text format     Abstract available


    July 2017
  4. WANG X, Gao Y, Wang B, Zhang Z, et al
    Analytic and Clinical Validation of an Ultrasensitive, Quantitative Polymerase Chain Reaction Assay for EGFR Mutation Analysis With Circulating Tumor DNA.
    Arch Pathol Lab Med. 2017;141:978-984.
    PubMed     Text format     Abstract available


    June 2017
  5. JAIN D, Allen TC, Aisner DL, Beasley MB, et al
    Rapid On-Site Evaluation of Endobronchial Ultrasound-Guided Transbronchial Needle Aspirations for the Diagnosis of Lung Cancer: A Perspective From Members of the Pulmonary Pathology Society.
    Arch Pathol Lab Med. 2017 Jun 22. doi: 10.5858/arpa.2017-0114.
    PubMed     Text format     Abstract available


    December 2016
  6. BAHAMON BN, Gao F, Danaee H
    Development and Validation of an ERCC1 Immunohistochemistry Assay for Solid Tumors.
    Arch Pathol Lab Med. 2016;140:1397-1403.
    PubMed     Text format     Abstract available


    November 2016
  7. DACIC S
    Lung Carcinoma Staging Update.
    Arch Pathol Lab Med. 2016.
    PubMed     Text format     Abstract available


  8. DOLLED-FILHART M, Locke D, Murphy T, Lynch F, et al
    Development of a Prototype Immunohistochemistry Assay to Measure Programmed Death Ligand-1 Expression in Tumor Tissue.
    Arch Pathol Lab Med. 2016;140:1259-1266.
    PubMed     Text format     Abstract available


    October 2016
  9. PADMANABHAN V, Steinmetz HB, Rizzo EJ, Erskine AJ, et al
    Improving Adequacy of Small Biopsy and Fine-Needle Aspiration Specimens for Molecular Testing by Next-Generation Sequencing in Patients With Lung Cancer: A Quality Improvement Study at Dartmouth-Hitchcock Medical Center.
    Arch Pathol Lab Med. 2016.
    PubMed     Text format     Abstract available


  10. ZAKOWSKI MF, Rekhtman N, Auger M, Booth CN, et al
    Morphologic Accuracy in Differentiating Primary Lung Adenocarcinoma From Squamous Cell Carcinoma in Cytology Specimens.
    Arch Pathol Lab Med. 2016;140:1116-20.
    PubMed     Text format     Abstract available


  11. CHURG A, Attanoos R, Borczuk AC, Chirieac LR, et al
    Dataset for Reporting of Malignant Mesothelioma of the Pleura or Peritoneum: Recommendations From the International Collaboration on Cancer Reporting (ICCR).
    Arch Pathol Lab Med. 2016;140:1104-10.
    PubMed     Text format     Abstract available


    September 2016
  12. ZHOU F, Moreira AL
    Lung Carcinoma Predictive Biomarker Testing by Immunoperoxidase Stains in Cytology and Small Biopsy Specimens: Advantages and Limitations.
    Arch Pathol Lab Med. 2016.
    PubMed     Text format     Abstract available


    August 2016
  13. DOLLED-FILHART M, Roach C, Toland G, Stanforth D, et al
    Development of a Companion Diagnostic for Pembrolizumab in Non-Small Cell Lung Cancer Using Immunohistochemistry for Programmed Death Ligand-1.
    Arch Pathol Lab Med. 2016.
    PubMed     Text format     Abstract available


  14. MILLER RA, Cagle PT, Bernicker EH
    First-Line Immune Therapy-Implications for Pathologists.
    Arch Pathol Lab Med. 2016;140:739-40.
    PubMed     Text format    


    May 2016
  15. SHOLL LM, Aisner DL, Allen TC, Beasley MB, et al
    Liquid Biopsy in Lung Cancer.
    Arch Pathol Lab Med. 2016.
    PubMed     Text format     Abstract available


    April 2016
  16. ROY-CHOWDHURI S, Aisner DL, Allen TC, Beasley MB, et al
    Biomarker Testing in Lung Carcinoma Cytology Specimens: A Perspective From Members of the Pulmonary Pathology Society.
    Arch Pathol Lab Med. 2016.
    PubMed     Text format     Abstract available


  17. SAUTER JL, Butnor KJ
    Clinical and Cost Implications of Universal Versus Locally Advanced-Stage and Advanced-Stage-Only Molecular Testing for Epidermal Growth Factor Receptor Mutations and Anaplastic Lymphoma Kinase Rearrangements in Non-Small Cell Lung Carcinoma: A Tertia
    Arch Pathol Lab Med. 2016;140:358-61.
    PubMed     Text format     Abstract available


  18. CAGLE PT, Allen TC, Bernicker EH, Ge Y, et al
    Impact of Recent Developments in Lung Cancer on the Practice of Pathology.
    Arch Pathol Lab Med. 2016;140:322-5.
    PubMed     Text format     Abstract available


  19. SHI J, Liu H, Ma XJ, Chen Z, et al
    Ribonucleic Acid In Situ Hybridization Is a More Sensitive Method Than Immunohistochemistry in Detection of Thyroid Transcription Factor 1 and Napsin A Expression in Lung Adenocarcinomas.
    Arch Pathol Lab Med. 2016;140:332-40.
    PubMed     Text format     Abstract available


  20. SHOLL LM, Aisner DL, Allen TC, Beasley MB, et al
    Programmed Death Ligand-1 Immunohistochemistry--A New Challenge for Pathologists: A Perspective From Members of the Pulmonary Pathology Society.
    Arch Pathol Lab Med. 2016;140:341-4.
    PubMed     Text format     Abstract available


  21. KERR KM, Hirsch FR
    Programmed Death Ligand-1 Immunohistochemistry: Friend or Foe?
    Arch Pathol Lab Med. 2016;140:326-31.
    PubMed     Text format     Abstract available


  22. DRIVER BR, Portier BP, Mody DR, Deavers M, et al
    Next-Generation Sequencing of a Cohort of Pulmonary Large Cell Carcinomas Reclassified by World Health Organization 2015 Criteria.
    Arch Pathol Lab Med. 2016;140:312-7.
    PubMed     Text format     Abstract available


    March 2016
  23. KERR KM, Nicolson MC
    Non-Small Cell Lung Cancer, PD-L1, and the Pathologist.
    Arch Pathol Lab Med. 2016;140:249-54.
    PubMed     Text format     Abstract available


  24. BERNICKER E
    Next-Generation Sequencing and Immunotherapy Biomarkers: A Medical Oncology Perspective.
    Arch Pathol Lab Med. 2016;140:245-8.
    PubMed     Text format     Abstract available


  25. THUNNISSEN E, Blaauwgeers HJ, de Cuba EM, Yick CY, et al
    Ex Vivo Artifacts and Histopathologic Pitfalls in the Lung.
    Arch Pathol Lab Med. 2016;140:212-20.
    PubMed     Text format     Abstract available


    January 2016
  26. BORCZUK AC, Allen TC
    PD-L1 and Lung Cancer: The Era of Precision-ish Medicine?
    Arch Pathol Lab Med. 2016.
    PubMed     Text format     Abstract available


    December 2015
  27. CAGLE PT, Bernicker EH
    Challenges to Biomarker Testing for PD-1/PD-L1 Checkpoint Inhibitors for Lung Cancer.
    Arch Pathol Lab Med. 2015;139:1477-8.
    PubMed     Text format    


    November 2015
  28. CAGLE PT, Bernicker EH
    A New Immunotherapy Drug Creates a Watershed for the Surgical Pathologist's Role in Patient Care.
    Arch Pathol Lab Med. 2015;139:1329.
    PubMed     Text format    


    October 2015
  29. LAGSTEIN A
    Pulmonary Apical Cap-What's Old Is New Again.
    Arch Pathol Lab Med. 2015;139:1258-62.
    PubMed     Text format     Abstract available


  30. PANG JC, Roh MH
    Metastases to the Pancreas Encountered on Endoscopic Ultrasound-Guided, Fine-Needle Aspiration.
    Arch Pathol Lab Med. 2015;139:1248-52.
    PubMed     Text format     Abstract available


    September 2015
  31. VOLMAR KE, Idowu MO, Souers RJ, Nakhleh RE, et al
    Molecular Testing in Anatomic Pathology and Adherence to Guidelines: A College of American Pathologists Q-Probes Study of 2230 Testing Events Reported by 26 Institutions.
    Arch Pathol Lab Med. 2015;139:1115-24.
    PubMed     Text format     Abstract available


  32. LI X, Brownlee NA, Sporn TA, Mahar A, et al
    Malignant (Diffuse) Mesothelioma in Patients With Hematologic Malignancies: A Clinicopathologic Study of 45 Cases.
    Arch Pathol Lab Med. 2015;139:1129-36.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Lung Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: